search Created with Sketch.
search Created with Sketch.

Advertisement

Dermatology Dispatches Logo
Dermatology Dispatches Logo

Toxin Time: What’s New and Exciting with Neuromodulators

April 8, 2020

Joel L. Cohen, MD, FAAD

Joel Cohen, MD takes a deep dive into the most recent data on neuromodulators including post-hoc analyses on the potential durability of response. Dr. Cohen also shares updates on Revance’s DAXI, Botox Cosmetic and liquid toxins under development by Galderma and Allergan.

Advertisement

Advertisement